Squamous cell carcinoma of the hoof wall in a stallion.

The research article discusses a specific case where a 15-year-old Thoroughbred stallion developed squamous cell carcinoma in its hoof wall, which led to other complications. This underlines the necessity for accurate diagnosis of equine hoof wall masses to effectively differentiate between benign and malignant conditions.

Patent’s Clinical Features

• The study centers on a 15-year-old Thoroughbred stallion presenting with a squamous cell carcinoma of the hoof wall, which further invaded the horse’s right hind distal phalanx(X-ray confirmation).
• Clinical signs included a chronic grade 2/5 right hind limb lameness and a non-sensitive sessile dorsal hoof wall mass.
• Radiography showed a well-circumscribed circular transparency within the distal phalanx, right beneath the visibly noticed hoof wall mass. These features led to the belief it was a hoof wall keratoma (benign).

Surgical Intervention and Outcome

• Surgical intervention on the horse was performed 10 months after initial examination.
• Despite the pre-surgery belief that the horse had a benign condition (keratoma), histological examination during surgery confirmed the mass to be squamous cell carcinoma – a type of skin cancer.
• Eight months post-surgery, the tumor had progressively invaded the distal phalanx, causing a pathologic articular fracture. This is a fracture that occurs in a bone that has been compromised by disease.

Significance of the Study

• The study emphasizes the importance of reaching an accurate histological diagnosis for equine hoof wall masses.
• For this stallion, an initial incorrect diagnosis led to a significant delay in the administration of appropriate treatment, allowing the cancer to progress and causing further health complications.
• Therefore, to differentiate between benign conditions like a hoof wall keratoma and more serious conditions like squamous cell carcinoma, histologic examination is crucial. This facilitates timely and accurate treatment, potentially preventing further disease progression and associated complications.